Sunday, May 19, 2013
"Concise industry news from the US pharmaceutical industry..."
Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Platinum Sponsors
Nanopoint, Inc.
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
is a privately-held biotechnology company that develops and markets unique cellular imaging systems for the life sciences market.
Read More
Gold Sponsors
Waters Corp.
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
For 50 years, Waters has developed innovative analytical science solutions to support customer discoveries, operations, performance, and regulatory compliance.
Read More
Silver Sponsors
Blog
Spencer Green
Chairman, GDS International
Chairman, GDS International
Sales and the 'Talent Magnet'
A lot is written about being a ‘Talent Magnet’, either as a company, or as President. It’s all good practice – listen, mentor, reward, provide clear goals and career maps. Good practice for the employer, but what about the employee?26 May 2011
White Papers
Focus Areas
Cover Stories
Towards a greener future
GSK’s Mark Rhodes examines the level of environmental awareness in the pharmaceutical industry.
Lifespans and livelihoods
In this address given to Town Hall Los Angeles in January, CEO of Eli Lilly and Company John Lechleiter.
Curing the world's ills?
With emerging markets poised to contribute more than 50 percent of the pharmaceutical industry’s growth in the next year, most of the big...
Roundtables
-
Using IT to improve success rates
NGP gathers some of the industry’s leading experts to discuss how technology can support and develop the discovery process. With Amos Dor of Umetrics and Patrick Flanagan...Read more
Vendor Perspectives
-
CMO PAT implementation: Time for strateg...
By Siemens. Process analytical technology (PAT) is a vital step towards a future where continuous manufacturing and real time product release can become real in the...Read more -
NanoInk
Nanotechnology offers the pharmaceutical industry new opportunities to optimize the drug discovery process.Read more
Industry Analysts
-
Breaking flow cytometric paradigms
Grant Howes of Accuri Cytometers explains why a multi-faceted single instrument is most efficient for researchers.Read more -
Leapfrog time?
The potential of continuous processing in secondary manufacturing. By Rebecca Vangenechten and Ivo Backx of Siemens AGRead more -
Quality data
Understanding the final FDA guidance for patient reported outcomes. By Scott Dixon, Phase ForwardRead more -
A hosted electronic notebook for life scie...
How an online hosted ELN helps scientists do more with less in the lab. By John McCarthy, Symyx Technologies, Inc.Read more -
Streamlining data
Amy Furlong of ERT explains why a centralized data system is more reliable.Read more -
Effective site management
Christene Leiper of Onorach explains how identifying key challenges and improving site management can save time and reduce costs.Read more
Executive Interviews
Understanding the new prescribing influences
Tom Haskell and John Moran of IMS’ Innovation Lab discuss how to evaluate new factors driving prescribing decisions.
Read more
Rise of biologics
Nitin Sood of Agilent Automation Solutions explains the expansion of automation trends in life sciences.
Read more
Understanding emerging markets
Eurand's Andrew Thompson shares insights on preparing for success in emerging markets.
Read more
Next Generation Healthcare Summit
25th - 27th October 2010
As healthcare costs continue to rise, health providers around the country feel a sharp sense of urgency in deploying information technology to lower costs, reduce medical errors, enhance outcomes, and spur efficiency in an industry known for legendary inefficiency.
Source: www.ngpharma.com© 2013 GDS Publishing Ltd. All rights reserved.